Celldex Therapeutics | CLDX - Trade Creditors

Stock Price
30.06
Daily Change
5.22 21.01%
Monthly
13.14%
Yearly
45.71%
Q1 Forecast
22.31

Celldex Therapeutics reported $4.27M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agenus USD 85.29M 10.89M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Celldex Therapeutics USD 4.27M 2.19M Sep/2025
Glaxosmithkline GBP 21.07B 7.42B Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Northwest Biotherapeutics 27.22M 5.8M Mar/2025
Pfizer USD 5.02B 142M Sep/2025
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025